Auto1 Group Se AUTO1 GROUP ORD SH.../ DE000A2LQ884 /
| 2024-05-16 6:33:05 PM | Chg. -0.310 | Volume | Bid2024-05-16 | Ask2024-05-16 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 7.100EUR | -4.19% | 5,231 Turnover: 36,279.411 |
-Bid Size: - | -Ask Size: - | 1.22 bill.EUR | - | - |
GlobeNewswire
05-14
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire
04-24
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of ob...
GlobeNewswire
04-02
Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the Europe...
GlobeNewswire
03-14
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
GlobeNewswire
03-12
Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certificati...
GlobeNewswire
02-08
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire
02-08
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire
01-22
Autolus Therapeutics announces acceptance of Biologics License Application for obecabtagene autoleuc...
GlobeNewswire
2023-12-10
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annu...
GlobeNewswire
2023-11-27
Autolus Therapeutics Submits Biologics License Application to U.S. Food and Drug Administration for ...
GlobeNewswire
2023-11-15
Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) An...
GlobeNewswire
2023-11-02
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) An...
GlobeNewswire
2023-11-02
Autolus Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
GlobeNewswire
2023-09-05
Autolus Therapeutics announces data from AUTO1/22 trial in pediatric Acute Lymphoblastic Leukemia pu...
GlobeNewswire
2022-03-10
Autolus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Pro...
GlobeNewswire
2021-11-04
Autolus Therapeutics to Present New Data at the 63rd ASH Annual Meeting & Exposition
GlobeNewswire
2021-11-03
Autolus Therapeutics Reports Third Quarter 2021 Financial Results and Operational Progress
GlobeNewswire
2021-09-09
Flo Announces $50 Million Series B Funding Round; Bringing Company to $800M Valuation
GlobeNewswire
2021-09-01
Autolus Therapeutics announces publication of obe-cel (AUTO1) Phase 1 ALLCAR19 data in adults with r...
GlobeNewswire
2021-08-09
Autolus Therapeutics Announces Promising Innovative Medicine (PIM) designation for obe-cel for the t...
GlobeNewswire
2021-08-05
Autolus Therapeutics Reports Second Quarter 2021 Financial Results and Operational Progress
GlobeNewswire
2021-06-15
Autolus Therapeutics Announces Innovation Licensing and Access Pathway (ILAP) designation for obe-ce...
